{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:15:25Z","timestamp":1789539325457,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>A large repertoire of IgA is produced by B lymphocytes with T-independent and T-dependent mechanisms useful in defense against pathogenic microorganisms and to reduce immune activation. IgA is active against several pathogens, including rotavirus, poliovirus, influenza virus, and SARS-CoV-2. It protects the epithelial barriers from pathogens and modulates excessive immune responses in inflammatory diseases. An early SARS-CoV-2 specific humoral response is dominated by IgA antibodies responses greatly contributing to virus neutralization. The lack of anti-SARS-Cov-2 IgA and secretory IgA (sIgA) might represent a possible cause of COVID-19 severity, vaccine failure, and possible cause of prolonged viral shedding in patients with Primary Antibody Deficiencies, including patients with Selective IgA Deficiency. Differently from other primary antibody deficiency entities, Selective IgA Deficiency occurs in the vast majority of patients as an asymptomatic condition, and it is often an unrecognized, Studies are needed to clarify the open questions raised by possible consequences of a lack of an IgA response to SARS-CoV-2.<\/jats:p>","DOI":"10.3389\/fcimb.2021.655896","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T09:15:22Z","timestamp":1617700522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":84,"title":["IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection"],"prefix":"10.3389","volume":"11","author":[{"given":"Isabella","family":"Quinti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Piano","family":"Mortari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Fernandez Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Milito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Carsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00685","article-title":"Patients with\u00a0Primary\u00a0Immunodeficiencies are a reservoir of Poliovirus and a risk to Polio eradication","volume":"8","author":"Aghamohammadi","year":"2017","journal-title":"Front. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/infdis\/jiv281","article-title":"Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults","volume":"212","author":"Bagga","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3364","article-title":"Are we underestimating seroprevalence of SARS-CoV-2","volume":"370","author":"Burgess","year":"2020","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02937","article-title":"Lack of Gut Secretory Immunoglobulin A in Memory B-Cell Dysfunction-Associated Disorders: A Possible Gut-Spleen Axis","volume":"10","author":"Carsetti","year":"2020","journal-title":"Front. Immunol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.610300","article-title":"Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases","volume":"11","author":"Carsetti","year":"2020","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-immunol-031210-101317","article-title":"Immunoglobulin responses at the mucosal interface","volume":"29","author":"Cerutti","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host","volume":"383","author":"Choi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/s41467-020-18058-8","article-title":"A cross reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction","volume":"11","author":"Ejemel","year":"2020","journal-title":"Nat. Commun."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101735","article-title":"Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk","volume":"23","author":"Fox","year":"2020","journal-title":"iScience"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100193","article-title":"Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19","volume":"2","author":"Goh","year":"2021","journal-title":"Cell Rep. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1016\/j.celrep.2020.02.022","article-title":"The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory","volume":"30","author":"Grimsholm","year":"2020","journal-title":"Cell Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01131.x","article-title":"Selective IgA\u00a0deficiency\u00a0(SIgAD) and common variable immunodeficiency (CVID)","volume":"120","author":"Hammarstr\u00f6m","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaip.2020.09.052","article-title":"Clinical outcomes and features of\u00a0COVID-19\u00a0in patients with primary immunodeficiencies in New York City","volume":"9","author":"Ho","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00872","article-title":"Defining Natural Antibodies","volume":"8","author":"Holodick","year":"2017","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.celrep.2017.08.036","article-title":"Strong clonal relatedness between Serum and Gut IgA despite different plasma cell origins","volume":"20","author":"Iversen","year":"2017","journal-title":"Cell Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.0105-2896.2005.00278.x","article-title":"The polymeric immunoglobulin receptor: Bridging innate and adaptive immune responses at mucosal surfaces","volume":"206","author":"Kaetzel","year":"2005","journal-title":"Immunol. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0220196","DOI":"10.1371\/journal.pone.0220196","article-title":"Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus","volume":"14","author":"Kim","year":"2019","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/thoraxjnl-2012-202288","article-title":"Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF","volume":"68","author":"McNamara","year":"2013","journal-title":"Thorax"},{"key":"B22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","article-title":"Coronavirus disease 2019 in patients with inborn errors of immunity: An international study","volume":"147","author":"Meyts","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3164\/jcbn.20-102","article-title":"Association between selective IgA deficiency and COVID-19","volume":"67","author":"Naito","year":"2020","journal-title":"J. Clin. Biochem. Nutr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1126\/science.286.5447.2156","article-title":"Control of early viral and bacterial distribution and disease by natural antibodies","volume":"286","author":"Ochsenbein","year":"1999","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e00408","DOI":"10.1128\/JVI.00408-20","article-title":"Potential role of Nonneutralizing IgA antibodies in cross-protective immunity against Influenza A viruses of multiple hemagglutinin subtypes","volume":"94","author":"Okuya","year":"2020","journal-title":"J. Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e881","DOI":"10.1212\/NXI.0000000000000881","article-title":"Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency","volume":"7","author":"Pfeuffer","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1183\/09031936.01.00228801","article-title":"Lung mucosal immunity: immunoglobulin-A revisited","volume":"18","author":"Pilette","year":"2011","journal-title":"Eur. Respir. J."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01283","article-title":"IGA Antibody Induced by Immunization With Pneumococcal Polysaccharides Is a Prognostic Tool in Common Variable Immune Deficiencies","volume":"11","author":"Pulvirenti","year":"2020","journal-title":"Front. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.jaip.2020.04.003","article-title":"Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic","volume":"8","author":"Pulvirenti","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia","volume":"146","author":"Quinti","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2021.1873767","article-title":"Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic","volume":"15","author":"Quinti","year":"2021","journal-title":"Expert Rev. Clin. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1007427","DOI":"10.1371\/journal.ppat.1007427","article-title":"IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody","volume":"15","author":"Saito","year":"2019","journal-title":"PloS Pathog."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e70867","DOI":"10.1371\/journal.pone.0070867","article-title":"IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization","volume":"8","author":"Schlaudecker","year":"2013","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000510251","article-title":"When Therapeutic IgA Antibodies Might Come of Age","volume":"106","author":"Sterlin","year":"2021","journal-title":"Pharmacology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human Inborn Errors of Immunity: 2019 Update on the\u00a0Classification from the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1080\/21645515.2018.1438791","article-title":"IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration","volume":"14","author":"Terauchi","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1016\/j.vaccine.2012.04.109","article-title":"Mucosal IgA responses in influenza virus infections; thoughts for vaccine design","volume":"30","author":"van Riet","year":"2012","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12931-015-0201-y","article-title":"Cigarette smoke inhibits BAFF expression and mucosal immunoglobulin A responses in the lung during influenza virus infection","volume":"16","author":"Wang","year":"2015","journal-title":"Respir. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"eabf1555","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B43","unstructured":""},{"key":"B44","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.655896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T09:15:24Z","timestamp":1617700524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.655896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":44,"alternative-id":["10.3389\/fcimb.2021.655896"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2021.655896","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"article-number":"655896"}}